Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 20, 2020 | Series B | €10.50M | 5 | Fountain Healthcare Partners | — | Detail |
Sep 26, 2019 | Series A | €8M | 4 | Fountain Healthcare Partners | — | Detail |
Sep 29, 2015 | Series A | €6.80M | 1 | Fountain Healthcare Partners | — | Detail |
Jun 23, 2011 | Seed | €200K | 1 | Enterprise Ireland | — | Detail |
Jan 1, 2010 | Series Unknown | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Fountain Healthcare Partners | Yes | Series B |
Enterprise Ireland | Yes | Seed |
Medical Device Resources | — | Series B |
Moffett Investment Holdings | — | Series B |
Kreos Capital | — | Series B |
Silicon Valley Bank | — | Series B |
NDRC | — | Series Unknown |